Pharmacoeconomic study of active psoriatic arthritis treatment

Objective: to conduct a clinical and economic analysis of the therapy for adult patients with psoriatic arthritis (PsA) using netakimab, a Russian interleukin-17 inhibitor, in comparison with other biological (b) and targeted synthetic (ts) disease-modifying antirheumatic drugs (DMARDs), available o...

Full description

Saved in:
Bibliographic Details
Main Authors: A. V. Rudakova, Т. V. Korotaeva
Format: Article
Language:Russian
Published: IRBIS LLC 2025-02-01
Series:Фармакоэкономика
Subjects:
Online Access:https://www.pharmacoeconomics.ru/jour/article/view/1139
Tags: Add Tag
No Tags, Be the first to tag this record!